AbCellera Biologics Inc. (ABCL) has 45 open-market insider trades by 10 insiders since 2020. Over the last six months insiders net bought $1.6M. The most active filer is Thermopylae Holdings Ltd., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Carl L. G. Hansen | CEO | — | 1 | $279.3M | 2024-11-25 |
| Thermopylae Holdings Ltd. | 10% Owner | — | 13 | $172.4M | 2026-02-27 |
| Peter Thiel | Dir | — | 1 | $60.0M | 2020-12-15 |
| Andrew Booth | CFO | — | 6 | $32.7M | 2026-08-14 |
| Veronique Lecault | COO | — | 5 | $31.4M | 2024-06-21 |
| Tryn Stimart | CLO | — | 2 | $25.5M | 2021-06-09 |
| Ester Falconer | CTO | — | 1 | $25.5M | 2021-09-01 |
| John Hamer | Dir | — | 1 | $10.2M | 2021-09-01 |
| Michael R. Hayden | Dir | — | 6 | $5.3M | 2026-08-24 |
| John S. Montalbano | Dir | — | 9 | $1.2M | 2026-08-18 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael R. Hayden | Director | Buy | $570K | 2026-08-24 |
| John S. Montalbano | Director | Buy | $110K | 2026-08-18 |
| Andrew Booth | CFO | Buy | $384K | 2026-08-14 |
| Michael R. Hayden | Director | Buy | $481K | 2026-08-12 |
| John S. Montalbano | Director | Buy | $95K | 2026-05-14 |
| Andrew Booth | CFO | Buy | $146K | 2026-02-27 |
Companies that share insiders with ABCL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Thermopylae Holdings Ltd. | 10% | Buy | $131K | 2026-02-27 |
| Thermopylae Holdings Ltd. | 10% | Buy | $580K | 2026-02-26 |
| John S. Montalbano | Director | Buy | $179K | 2025-11-26 |
| Thermopylae Holdings Ltd. | 10% Owner | Buy | $1.5M | 2025-03-11 |
| John S. Montalbano | Director | Buy | $115K | 2025-03-10 |
| John S. Montalbano | Director | Buy | $140K | 2025-03-06 |
| Thermopylae Holdings Ltd. | 10% Owner | Buy | $1.5M | 2024-08-29 |
| John S. Montalbano | Director | Buy | $137K | 2023-11-06 |
| Michael R. Hayden | Director | Buy | $98K | 2023-09-22 |